Certificate of Analysis
Purity
≥98.0%
Method
HPLC / MS
Testing
Third-Party
COA Status
Available
Retatrutide
A triple-receptor research agonist studied in laboratory models involving GLP-1, GIP, and glucagon receptor pathway analysis and metabolic signaling characterization.
Select Size / Specification
Selected: 5mg x 10vials
Choose Pack Size
Quantity
Research Use Only — All products are intended strictly for laboratory research purposes and are not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Pricing & Specifications
| Specification | Strength | Pack | Total Qty | 1 Vial | 3 Vial Bundle | 10 Vial Kit | Kit Savings |
|---|---|---|---|---|---|---|---|
| 5mg x 10vials | 5 MG | 10 | 50 MG | $85.00 | $242.25 | $637.5025% off | $212.50 |
| 10mg x 10vials | 10 MG | 10 | 100 MG | $145.00 | $413.25 | $1,087.5025% off | $362.50 |
| 15mg x 10vials | 15 MG | 10 | 150 MG | $195.00 | $555.75 | $1,462.5025% off | $487.50 |
| 20mg x 10vials | 20 MG | 10 | 200 MG | $245.00 | $698.25 | $1,837.5025% off | $612.50 |
| 30mg x 10vials | 30 MG | 10 | 300 MG | $345.00 | $983.25 | $2,587.5025% off | $862.50 |
| 50mg x 10vials | 50 MG | 10 | 500 MG | $525.00 | $1,496.25 | $3,937.5025% off | $1,312.50 |
| 60mg x 10vials | 60 MG | 10 | 600 MG | $615.00 | $1,752.75 | $4,612.5025% off | $1,537.50 |
About Retatrutide
Retatrutide (LY3437943) is a novel synthetic peptide designed as a simultaneous agonist at three metabolic hormone receptors: the glucose-dependent insulinotropic polypeptide receptor (GIP-R), the glucagon-like peptide-1 receptor (GLP-1-R), and the glucagon receptor (GCGR). The 39-residue sequence incorporates fatty acid-based albumin-binding modification strategies analogous to semaglutide, combined with a pharmacophore that enables engagement of the distinct N-terminal extracellular domains of all three target receptors. This triple-agonist design represents a newer structural class of incretin-based research peptides.
Laboratory investigations of retatrutide have examined its tripartite receptor activation profile, including relative potency at each receptor subtype in cell-based assay systems, and the resultant effects on adenylyl cyclase activity and downstream metabolic signaling cascades. Research interest encompasses comparative pharmacodynamics versus dual-receptor agonists and the structural requirements for balanced agonism across structurally related Family B GPCRs. All research applications are intended for qualified researchers conducting controlled in vitro or preclinical studies.
Peptide / Compound Information
| Property | Value |
|---|---|
| Peptide Sequence | Triple receptor agonist: GIP-R / GLP-1-R / Glucagon-R (39 AA with C18 fatty diacid modification) |
| Molecular Formula | C222H369N59O68S |
| Molecular Weight | 4,975.8 g/mol |
| CAS Number | 2381289-90-1 |
| Synonyms | LY3437943, GIP/GLP-1/Glucagon Triple Agonist |
Lyophilized Research Peptides
This product is supplied in lyophilized (freeze-dried) form — a process that extends shelf life and preserves peptide purity and structural integrity during storage. No fillers, excipients, or preservatives are used in the lyophilization process. The lyophilized powder should be reconstituted with an appropriate research-grade solvent in a controlled laboratory environment prior to use in in vitro or preclinical assay systems.
99%+
PURITY
Third Party Tested
Independently verified by ISO-accredited laboratories. Batch-specific COAs available on request.
GMP
CERT.
GMP Manufacturing Standards
Synthesized in registered facilities following Good Manufacturing Practices with full chain-of-custody documentation.
FAST
SHIP
Best in Class Fulfillment
Same-day fulfillment on qualifying orders. Secure cold-chain packaging. Domestic and international research shipping.
ZERO
FILLERS
Zero Fillers or Additives
Pure active compounds only. Lyophilized without fillers or preservatives. Composition independently verified.
Scientific Content Review
All technical product descriptions, molecular data, and research context on this page have been prepared with reference to published scientific literature and PubChem compound databases. Content is intended for informational purposes in a research catalog context and does not constitute medical advice or claim therapeutic efficacy.
Retatrutide is a research compound available for controlled laboratory investigation and scientific study. This product is intended strictly for in vitro research, preclinical investigation, and analytical characterization by qualified researchers. Not for human consumption.
Category
GLP-1 / Metabolic
Purity
≥98.0%
Available Sizes
5MG, 10MG, 15MG, 20MG, 30MG, 50MG, 60MG
COA
Available